Quick Takeaways
- S.H.N. Financial Investments Ltd. filed SCHEDULE 13G for Plus Therapeutics, Inc. Common Stock, $0.001 par value (PSTV).
- Disclosed ownership: 10%.
- Date of event: 04 Mar 2025.
S.H.N. Financial Investments Ltd. - 04 Mar 2025 SCHEDULE 13G Report for Plus Therapeutics, Inc. Common Stock, $0.001 par value (PSTV)
- Filing Manager
- S.H.N. Financial Investments Ltd.
- Reporting Manager
- S.H.N. Financial Investments Ltd.
- Symbol
- PSTV
- Shares outstanding
- 12,109,650 shares
- Disclosed Ownership
- 1,209,754 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 18 Mar 2025, 16:17:10 UTC
- Date of event
- 04 Mar 2025
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"S.H.N. Financial Investments Ltd. disclosed 10% ownership in Plus Therapeutics, Inc. Common Stock, $0.001 par value (PSTV) on 04 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Mar 2025, 16:17.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| S.H.N. Financial Investments Ltd. | 10% | 1,209,754 | 1,209,754 | 0 | /s/ Nir Shamir | Nir Shamir, Chief Executive Officer |